Markets:

Overview

News

Currencies

International

Treasuries

Corvus Pharmaceuticals, Inc. - Common Stock (NQ:CRVS)

19.34 +0.58 (+3.09%)

Streaming Delayed Price Updated: 1:10 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Corvus Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

3 High-Potential Penny Stocks to Buy Now ↗

May 31, 2023

When it comes to penny stocks to buy now, be aware of the risks. While some of these little guys can rocket, some will be duds.

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

May 17, 2023

Via Benzinga

Why Doximity Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

May 17, 2023

Gainers

Via Benzinga

Corvus Pharmaceuticals Earnings Preview ↗

March 27, 2023

Via Benzinga

Corvus Pharma's HIV Candidate Shows Potential To Prevent Virus Re-Emergence ↗

February 21, 2023

Via Benzinga

Earnings Scheduled For March 10, 2022 ↗

March 10, 2022

Companies Reporting Before The Bell • Despegar.com (NYSE:DESP) is expected to report quarterly loss at $0.08 per share on revenue of $110.93 million. • ProShares...

Via Benzinga

Why Venus Concept Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

May 15, 2023

Gainers NeoGames S.A. (NASDAQ: NGMS) shares climbed 113.3% to $27.38 as the company agreed to be acquired by Aristocrat Leisure Limited for $29.50 per share in cash.

Via Benzinga

Why Are Corvus Pharmaceuticals Trading Higher Today ↗

May 10, 2023

In its Q1 earnings release, Corvus Pharmaceuticals Inc (NASDAQ: CRVS) revealed updated data from the Phase 1/1b trial evaluating single-agent therapy with CPI-818 in patients with

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

May 10, 2023

Via Benzinga

7 High-Potential Penny Stocks in the Biotech Sector ↗

May 04, 2023

Most of the biggest biotech stocks on the market started off as unknown penny stocks. Here are seven hot ones to consider.

Via InvestorPlace

The 3 Best Biotech Stocks Under $1 to Buy for April ↗

April 04, 2023

While risky, here are some of the best biotech stocks under $1, with solid catalysts, investors may want to consider.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

April 04, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

February 21, 2023

Via Benzinga

$1 Million Bet On BioCardia? Check Out These 4 Penny Stocks Insiders Are Buying ↗

December 21, 2022

The Dow Jones settled higher on Tuesday after recording losses for four straight sessions. Investors, meanwhile, focused on some notable insider trades.

Via Benzinga

4 Penny Stocks Insiders Are Buying: Getaround, Corvus Pharmaceuticals And More ↗

December 16, 2022

The Dow Jones closed lower by over 700 points on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern...

Via Benzinga

Why OpGen Shares Are Trading Higher By 220%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session ↗

December 13, 2022

Gainers OpGen, Inc. (NASDAQ: OPGN) shares surged 220% to $0.3994 after the company announced topline data from its Unyvero urinary tract infections (UTI) clinical trial.

Via Benzinga

Earnings Preview For Corvus Pharmaceuticals ↗

November 02, 2022

Corvus Pharmaceuticals (NASDAQ:CRVS) is set to give its latest quarterly earnings report on Thursday, 2022-11-03. Here's what investors need to know before the announcement. Analysts estimate that...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 7, 2022 ↗

October 07, 2022

Upgrades

Via Benzinga

10 Best Stocks to Buy Now According to Jeffrey Diehl’s Adams Street Partners ↗

October 05, 2022

In this article, we will be taking a look at some of the top stocks in the portfolio of Jeffrey Diehl.

Via Talk Markets

Corvus Pharma's Partner Secures China Approval For Early-Stage Mupadolimab Trial For Lung, Head & Neck Cancer ↗

September 27, 2022

Via Benzinga

Corvus Pharmaceuticals: Q2 Earnings Insights ↗

August 08, 2022

Corvus Pharmaceuticals (NASDAQ:CRVS) reported its Q2 earnings results on Monday, August 8, 2022 at 04:05 PM. Here's what investors need to know about the announcement.

Via Benzinga

This Healthcare Stock Jumps Around 188%, Here's 83 Biggest Movers From Yesterday ↗

June 28, 2022

Gainers Evofem Biosciences, Inc. (NASDAQ: EVFM) shares jumped 187.7% to close at $1.07 on Monday amid the Supreme Court overturning Roe V Wade.

Via Benzinga

Carnival Surges Over 12%, Here's 75 Biggest Movers From Friday ↗

June 27, 2022

Gainers USA Truck, Inc. (NASDAQ: USAK) shares climbed 112.6% to close at $31.00 on Friday. DB Schenker and USA Truck announced plans to combine and create premier North American transportation...

Via Benzinga

Recap: Corvus Pharmaceuticals Q4 Earnings ↗

March 10, 2022

Corvus Pharmaceuticals (NASDAQ:CRVS) reported its Q4 earnings results on Thursday, March 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement....

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

April 20, 2022

On Wednesday, 160 companies hit new 52-week lows. Areas of Significance In Today's 52-Week Lows: Walt Disney (NYSE:DIS) was the largest firm by market cap to set a new...

Via Benzinga

A Preview Of Corvus Pharmaceuticals's Earnings ↗

March 09, 2022

Corvus Pharmaceuticals (NASDAQ:CRVS) is set to give its latest quarterly earnings report on Thursday, 2022-03-10. Here's what investors need to know before the announcement....

Via Benzinga

The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg ↗

March 06, 2022

Biotech stocks reversed course in the week ending March 4, as the Ukrainian crisis weighed down on the broader market as well as the sector. The iShares Biotechnology ETF (...

Via Benzinga

The Daily Biotech Pulse: Bausch Files For Eye Health Unit IPO, LumiraDx Antigen Test Can Detect Omicron, Molecular Partners Discloses Fund Stake ↗

January 14, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Corvus Says Chinese Angel Pharma Starts Phase 1/2 Blood Cancer Study Corvus...

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

December 17, 2021

Gainers GBS (NASDAQ:GBS

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

December 01, 2021

Gainers Ardelyx (NASDAQ:ARDX) stock increased by 19.29% to $1.36 during Wednesday's pre-market session. The market value of their outstanding shares is at $153.3...

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Corvus Pharmaceuticals, Inc. - Common Stock (NQ:CRVS)

Headline News about Corvus Pharmaceuticals, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today